BioTek Inducted into Deane C. Davis Vermont Business Hall of Fame
News Jun 14, 2011
BioTek Instruments was an inaugural inductee in the newly established Deane C. Davis Vermont Business Hall of Fame.
The ceremony, held on May 24, 2011 in the University of Vermont's Kalkin Hall, included past winners of the Deane C. Davis Outstanding Vermont Business of the Year Award, which is presented jointly by the Vermont Chamber of Commerce and Vermont Business Magazine.
BioTek President/CEO Briar Alpert and Vice President Adam Alpert jointly accepted the award on behalf of BioTek.
During his acceptance speech, Mr. Briar Alpert stressed BioTek's commitment to hiring, training and retaining Vermonters, and to bringing national and international revenue into the state.
Vermont Governor Peter Shumlin attended the ceremony, and noted, "Companies like BioTek are vital players in not only Vermont's economy, but Vermont's sense of community. This induction into the prestigious Deane C. Davis Vermont Business Hall of Fame is a well-earned recognition of the importance of BioTek, and I was pleased to be part of the ceremony marking that honor."
Researchers Develop New Method to Generate Human AntibodiesNews
Researchers hope their approach will help researchers rapidly generate therapeutic antibodies for the treatment of infectious diseases and other conditions such as cancer.READ MORE
Large-Scale Production of Living Brain Cells Enables Entirely New ResearchNews
After performing a biopsy on the patient, the skin cells are transformed into brain cells that effectively imitate the disease and the age of the patient.READ MORE
U.S. Study of Dapivirine Ring in Lactating Women Finds Little Drug Gets Into Breast MilkNews
The antiretroviral drug dapivirine that is released from an experimental vaginal ring to protect against HIV is absorbed in very low concentrations into breastmilk.READ MORE
Comments | 0 ADD COMMENT
EMBL Conference: European Conference of Life Science Funders and Foundations
Apr 19 - Apr 20, 2018
EMBL Course: Target Engagement in Biology and Drug Discovery
Feb 19 - Feb 23, 2018